NCT05320302View on ClinicalTrials.gov

A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

June 15, 2022

Study Completion Date

June 20, 2022

Conditions

Healthy Participants

Interventions

DRUG

[11C]-Lu AF88370

PET ligand in a single intravenous bolus injection

Trial Locations (1)

W12 0NN

Invicro, London

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY